identify
-
Aging and Longevity
Johns Hopkins Scientists Utilize Patient-Derived Brain Organoids to Predict Alzheimer’s Drug Response and Identify Novel Biomarkers
In a landmark study published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, researchers at Johns Hopkins Medicine…
Read More » -
Aging and Longevity
King’s College London Researchers Identify Potential Breakthrough in Alzheimer’s Treatment Through Multi-Targeted Drug KCL-286
In a significant advancement for neurodegenerative research, a team of scientists at King’s College London has unveiled a novel therapeutic…
Read More » -
Aging and Longevity
King’s College London Researchers Identify Potential Breakthrough in Alzheimer’s Treatment Through Dual-Action Drug KCL-286
In a significant advancement for neurodegenerative research, a team of scientists at King’s College London (KCL) has identified a promising…
Read More » -
Aging and Longevity
King’s College London Researchers Identify Breakthrough Multi-Target Drug Candidate KCL-286 for Early Stage Alzheimer’s Treatment
In a significant departure from traditional amyloid-centric research, a team of neuroscientists at King’s College London (KCL) has unveiled a…
Read More » -
Aging and Longevity
Johns Hopkins Researchers Identify CSE Protein and Hydrogen Sulfide as Critical Factors in Slowing Alzheimers Progression
Scientists at Johns Hopkins Medicine, supported by a significant new grant from the National Institutes of Health (NIH), have released…
Read More »
